Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI.
The acquisition of the full intellectual property, clients, and team from MotionHall enables the acceleration of multiple roadmaps, including targeted enhancements to Clarivate Cortellis™, market assessments, and a new Business Development and Licensing Enterprise Workbench.
London, March 21, 2024 /PRNewswire/: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has announced an agreement to acquire the substantial majority of the assets of MotionHall, a Silicon Valley technology start-up company serving the life sciences with vertical artificial intelligence (AI) solutions. The asset purchase serves as a key component of the Clarivate™ Life Sciences & Healthcare strategy to deliver transformative intelligence through the application of generative AI (GenAI) and proprietary industry vertical AI solutions. Clarivate provides people and organizations with transformative intelligence they can trust, propelling human ingenuity into our world’s greatest breakthroughs.
The acquisition of the full intellectual property, clients, and team from MotionHall enables the acceleration of multiple roadmaps, including targeted enhancements to Clarivate Cortellis™, market assessments, and a new Business Development and Licensing Enterprise Workbench.
Henry Levy, President, Life Sciences & Healthcare, Clarivate, said: “As part of our strategy, Clarivate will enhance existing products and introduce novel solutions utilizing AI to streamline clients’ workflows and accelerate speed to insight and action. Concurrent with this transaction, the team from MotionHall has joined Clarivate to progress our on-going commitment to provide exceptional value for our clients across the entire drug, device, and medical technology lifecycle.”
Rachael Craig, SVP and Managing Director, Life Sciences & Healthcare Strategy Products, Clarivate, said: “Clarivate is well positioned to become a leading industry vertical artificial intelligence (AI) player. Your healthier tomorrow is being built through the successful combination of deep life sciences industry expertise and mastery of frontier AI capabilities. Clients who choose Clarivate as we advance industry vertical AI together will have access to this frontier, becoming better equipped to deliver outcomes for their company and patients that meet today’s complex challenges.”
In the near term, Clarivate will leverage MotionHall IP to further enhance Cortellis search as well as the scope of data quality and coverage.
To learn more about Clarivate Portfolio Strategy and Business Development Solutions, visit https://clarivate.com/industries/life-sciences-and-healthcare/.
Also read: Women in the technology industry is constantly increasing, says Rajita Bhatnagar
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News, a proprietary of Mercadeo, produces award-winning content and resources for IT leaders across any industry through print articles and recorded video interviews on topics in the technology sector such as Digital Transformation, Artificial Intelligence (AI), Machine Learning (ML), Cloud, Robotics, Cyber-security, Data, Analytics, SOC, SASE, among other technology topics.
